For example, a lack of IL-6 in the TME augmented type-1 immunity, including the induction of antitumor cytotoxic T cells, and inhibited tumorigenesis of a CRC CT26 mouse model in vivo [69]. The gene discussed is IL6; the disease is colorectal carcinoma.